Cryptocurrency & Digital Assets

An 8-14% energy surcharge from a key chemical supplier highlights how the Middle East conflict is driving up industrial costs and disrupting supply chains.

Cannabis firm FLUENT Corp. takes on a high-interest $6M loan, revealing the harsh financial realities facing the federally illegal cannabis industry.

Reliance Jio and Good Game launch a massive reality show with a ₹1 crore prize, blending esports and entertainment to find India's first global gaming icon.

As AI demands unprecedented data speeds, one firm's award-winning tech overcomes a key physical barrier, setting a new benchmark for next-gen networks.

A new report reveals why immediate cash aid is now a crucial employer benefit, as rising costs force workers to raid their 401(k)s for emergencies.

JenaValve's Trilogy system gains historic FDA approval, offering a new, minimally invasive option for high-risk patients with a life-threatening heart condition.

Hertz is adding the rugged INEOS Grenadier 4x4 to its premium fleet, a strategic move tapping into the demand for unique, adventure-ready rentals.

New data suggests Phanes Therapeutics' bispecific antibody may overcome major side effects of CD47 inhibitors while showing promise in tough GI cancers.

FHFA's approval of VantageScore is igniting fierce competition, promising nearly $1B in savings and opening new paths to homeownership for millions.

Private equity firm Manna Tree hires Jennifer Roach as Managing Director, signaling a major play to dominate the booming consumer health and wellness market.

The company is moving its patented chemical-free water and fuel treatment tech from prototype to production, aiming to disrupt the industrial efficiency market.

New data on 1.3 million trips shows Orlando and Cancun are top spots, but rising costs and global risks are reshaping how Americans plan their getaways.

With veteran leader Brian McKelligon at the helm, Infinity Bio aims to commercialize its powerful MIPSA platform and redefine precision medicine.

A landmark deal between Australia's VVMF and UK's OXB aims to create a new cell and gene therapy manufacturing hub for the booming Asia-Pacific market.

The AI cloud firm's upsized $4.0 billion convertible note offering signals strong investor confidence as it races to build out data centers for mega-clients.

With a massive $68.7M seed round and novel T-cell engager tech, Shanghai's Excalipoint is pioneering a new model for rapid drug development.

With AI making traditional cyber defenses obsolete, RAVEN.IO has secured $20M to pioneer a new era of runtime security that looks inside applications.

A new report reveals security teams are drowning in alerts, wasting time on manual work while 79% of threats are found by outsiders first. Is AI the answer?

A Swiss app is paying users to explore their cities. Can this 'anti-scroll' model drive real-world discovery and challenge the giants of social media?

A novel drug mimicking exercise aims to solve a major problem with today's weight-loss meds: muscle loss. Atrogi's ATR-258 has entered a key human trial.